{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cholesterol biosynthesis", "ERK1/2", "FAM38A", "KLF2", "Leukemia progression", "Lovastatin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37016335", "DateCompleted": {"Year": "2023", "Month": "04", "Day": "06"}, "DateRevised": {"Year": "2023", "Month": "04", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "04", "Day": "04"}], "Language": ["eng"], "ELocationID": ["306", "10.1186/s12885-023-10742-4"], "Journal": {"ISSN": "1471-2407", "JournalIssue": {"Volume": "23", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Apr", "Day": "04"}}, "Title": "BMC cancer", "ISOAbbreviation": "BMC Cancer"}, "ArticleTitle": "Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling.", "Pagination": {"StartPage": "306", "MedlinePgn": "306"}, "Abstract": {"AbstractText": ["Lovastatin, an HMG-CoA inhibitor and an effective cholesterol lowering drug, exhibits anti-neoplastic activity towards several types of cancer, although the underlying mechanism is still not fully understood. Herein, we investigated mechanism of growth inhibition of leukemic cells by lovastatin.", "RNAseq analysis was used to explore the effect of lovastatin on gene expression in leukemic cells. An animal model of leukemia was used to test the effect of this statin in vivo. FAM83A and DDIT4 expression was knocked-downed in leukemia cells via lentivirus-shRNA. Western blotting, RT-qPCR, cell cycle analysis and apoptosis assays were used to determine the effect of lovastatin-induced growth suppression in leukemic cells in vitro.", "Lovastatin treatment strongly inhibited cancer progression in a mouse model of erythroleukemia induced by Friend virus. In tissue culture, lovastatin inhibited cell proliferation through induction of G<sub>1</sub> phase cell cycle arrest and apoptosis. Interestingly, lovastatin induced most known genes associated with cholesterol biosynthesis in leukemic cells. Moreover, it suppressed ERK1/2 phosphorylation by downregulating FAM83A and DDIT4, two mediators of MAP-Kinase signaling. RNAseq analysis of lovastatin treated leukemic cells revealed a strong induction of the tumor suppressor gene KLF2. Accordingly, lentivirus-mediated knockdown of KLF2 antagonized leukemia cell suppression induced by lovastatin, associated with higher ERK1/2 phosphorylation compared to control. We further show that KLF2 induction by lovastatin is responsible for lower expression of the FAM83A and DDIT4 oncogenes, involved in the activation of ERK1/2. KLF2 activation by lovastatin also activated a subset of cholesterol biosynthesis genes that may further contribute to leukemia suppression.", "These results implicate KLF2-mediated FAM83A/DDIT4/MAPK suppression and activation of cholesterol biosynthesis as the mechanism of leukemia cell growth inhibition by lovastatin."], "CopyrightInformation": "\u00a9 2023. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, 550014, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese, Academic of Sciences, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Gao", "ForeName": "Jian", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, 550014, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese, Academic of Sciences, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Hu", "ForeName": "Jifen", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, 550014, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese, Academic of Sciences, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Yu", "ForeName": "Fang", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, 550014, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese, Academic of Sciences, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Wang", "ForeName": "Chunlin", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, 550014, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese, Academic of Sciences, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Sheng", "ForeName": "Danmei", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, 550014, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese, Academic of Sciences, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Liu", "ForeName": "Wuling", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, 550014, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese, Academic of Sciences, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Hu", "ForeName": "Anling", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, 550014, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese, Academic of Sciences, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Yu", "ForeName": "Kunling", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, 550014, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese, Academic of Sciences, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Xiao", "ForeName": "Xiao", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, 550014, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese, Academic of Sciences, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Kuang", "ForeName": "Yi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Toronto, Toronto, ON, Canada."}, {"Identifier": [], "Affiliation": "Division of Advanced Diagnostics, Toronto General Research Institute, University Health Network, Toronto, ON, Canada."}], "LastName": "Zacksenhaus", "ForeName": "Eldad", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, 550014, People's Republic of China. babu@gmc.edu.cn."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese, Academic of Sciences, Guiyang, Guizhou, People's Republic of China. babu@gmc.edu.cn."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, Guizhou Province, 550025, People's Republic of China. babu@gmc.edu.cn."}], "LastName": "Gajendran", "ForeName": "Babu", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, 550014, People's Republic of China. yaacovbendavid@hotmail.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese, Academic of Sciences, Guiyang, Guizhou, People's Republic of China. yaacovbendavid@hotmail.com."}], "LastName": "Ben-David", "ForeName": "Yaacov", "Initials": "Y"}], "GrantList": [{"GrantID": "QKHJC-ZK[2022]YB297", "Agency": "Guizhou Science and Technology Department", "Country": ""}, {"GrantID": "QKHPTRC [2019]5627", "Agency": "Guizhou Science and Technology Department", "Country": ""}, {"GrantID": "82260040", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "U1812403", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "RN21025", "Agency": "Guizhou Medical University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Cancer", "NlmUniqueID": "100967800", "ISSNLinking": "1471-2407"}, "ChemicalList": [{"RegistryNumber": "9LHU78OQFD", "NameOfSubstance": "Lovastatin"}, {"RegistryNumber": "0", "NameOfSubstance": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}, {"RegistryNumber": "97C5T2UQ7J", "NameOfSubstance": "Cholesterol"}, {"RegistryNumber": "0", "NameOfSubstance": "Klf2 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Kruppel-Like Transcription Factors"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Lovastatin"}, {"QualifierName": ["drug therapy", "genetics"], "DescriptorName": "Leukemia, Erythroblastic, Acute"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Cholesterol"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["genetics"], "DescriptorName": "Kruppel-Like Transcription Factors"}], "CoiStatement": "The authors have declared that no competing interest exists."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Smith MB, Lee NJ, Haney E, Carson S. Drug class review: HMG-CoA reductase inhibitors (statins) and fixed-dose combination products containing a statin: final report update 5. Portland (OR): Oregon Health & Science University; 2009.", "ArticleIdList": ["21089253"]}, {"Citation": "Tobert JA. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. Nat Rev Drug Discov. 2003;2(7):517\u201326. doi: 10.1038/nrd1112.", "ArticleIdList": ["10.1038/nrd1112", "12815379"]}, {"Citation": "Mullen PJ, Yu R, Longo J, Archer MC, Penn LZ. The interplay between cell signalling and the mevalonate pathway in cancer. Nat Rev Cancer. 2016;16(11):718\u201331. doi: 10.1038/nrc.2016.76.", "ArticleIdList": ["10.1038/nrc.2016.76", "27562463"]}, {"Citation": "Longo J, van Leeuwen JE, Elbaz M, Branchard E, Penn LZ. Statins as anticancer agents in the era of precision medicine. Clin Cancer Res Off J Am Assoc Cancer Res. 2020;26(22):5791\u2013800. doi: 10.1158/1078-0432.CCR-20-1967.", "ArticleIdList": ["10.1158/1078-0432.CCR-20-1967", "32887721"]}, {"Citation": "Klawitter J, Shokati T, Moll V, Christians U, Klawitter J. Effects of lovastatin on breast cancer cells: a proteo-metabonomic study. Breast Cancer Res BCR. 2010;12(2):R16. doi: 10.1186/bcr2485.", "ArticleIdList": ["10.1186/bcr2485", "PMC2879560", "20205716"]}, {"Citation": "Martirosyan A, Clendening JW, Goard CA, Penn LZ. Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance. BMC Cancer. 2010;10:103. doi: 10.1186/1471-2407-10-103.", "ArticleIdList": ["10.1186/1471-2407-10-103", "PMC2847546", "20298590"]}, {"Citation": "Wong WW-L, Clendening JW, Martirosyan A, Boutros PC, Bros C, Khosravi F, et al. Determinants of sensitivity to lovastatin-induced apoptosis in multiple myeloma. Mol Cancer Ther. 2007;6(6):1886\u201397. doi: 10.1158/1535-7163.MCT-06-0745.", "ArticleIdList": ["10.1158/1535-7163.MCT-06-0745", "17575117"]}, {"Citation": "Smith B, Land H. Anticancer activity of the cholesterol exporter ABCA1 gene. Cell Rep. 2012;2(3):580\u201390. doi: 10.1016/j.celrep.2012.08.011.", "ArticleIdList": ["10.1016/j.celrep.2012.08.011", "PMC3462268", "22981231"]}, {"Citation": "Ikonen E. Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol. 2008;9(2):125\u201338. doi: 10.1038/nrm2336.", "ArticleIdList": ["10.1038/nrm2336", "18216769"]}, {"Citation": "Shafique K, McLoone P, Qureshi K, Leung H, Hart C, Morrison DS. Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years\u2019 follow up. BMC Cancer. 2012;12:25. doi: 10.1186/1471-2407-12-25.", "ArticleIdList": ["10.1186/1471-2407-12-25", "PMC3271031", "22260413"]}, {"Citation": "Kuzu OF, Noory MA, Robertson GP. The role of cholesterol in cancer. Cancer Res. 2016;76(8):2063\u201370. doi: 10.1158/0008-5472.CAN-15-2613.", "ArticleIdList": ["10.1158/0008-5472.CAN-15-2613", "PMC5813477", "27197250"]}, {"Citation": "Allott EH, Howard LE, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, et al. Serum lipid profile and risk of prostate cancer recurrence: results from the SEARCH database. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2014;23(11):2349\u201356. doi: 10.1158/1055-9965.EPI-14-0458.", "ArticleIdList": ["10.1158/1055-9965.EPI-14-0458", "PMC4221498", "25304929"]}, {"Citation": "Rosch PJ, McCully K. Statin use and reduced cancer-related mortality. N Engl J Med. 2013;368(6):576.", "ArticleIdList": ["23388016"]}, {"Citation": "Bjerre LM, LeLorier J. Do statins cause cancer? A meta-analysis of large randomized clinical trials. Am J Med. 2001;110(9):716\u201323. doi: 10.1016/S0002-9343(01)00705-7.", "ArticleIdList": ["10.1016/S0002-9343(01)00705-7", "11403756"]}, {"Citation": "Parsa N, Taravatmanesh S, Trevisan M. Is low cholesterol a risk factor for cancer mortality? Eur J Cancer Prev Off J Eur Cancer Prev Organ ECP. 2018;27(6):570\u20136. doi: 10.1097/CEJ.0000000000000391.", "ArticleIdList": ["10.1097/CEJ.0000000000000391", "28683011"]}, {"Citation": "Ravnskov U, Rosch PJ, McCully KS. Statins do not protect against cancer: quite the opposite. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33(7):810\u20131. doi: 10.1200/JCO.2014.58.9564.", "ArticleIdList": ["10.1200/JCO.2014.58.9564", "25605834"]}, {"Citation": "Wang N, Fan Y, Yuan C-M, Song J, Yao Y, Liu W, et al. Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity. BMC Cancer. 2019;19(1):764. doi: 10.1186/s12885-019-5914-8.", "ArticleIdList": ["10.1186/s12885-019-5914-8", "PMC6679490", "31375085"]}, {"Citation": "Yu F, Gajendran B, Wang N, Sample KM, Liu W, Wang C, et al. ERK activation via A1542/3 limonoids attenuates erythroleukemia through transcriptional stimulation of cholesterol biosynthesis genes. BMC Cancer. 2021;21(1):680. doi: 10.1186/s12885-021-08402-6.", "ArticleIdList": ["10.1186/s12885-021-08402-6", "PMC8191108", "34107900"]}, {"Citation": "Liu PC, Lu G, Deng Y, Wang CD, Su XW, Zhou JY, et al. Inhibition of NF-\u03baB pathway and modulation of MAPK signaling pathways in glioblastoma and implications for lovastatin and tumor necrosis factor-related apoptosis inducing ligand (TRAIL) combination therapy. PLoS ONE. 2017;12(1):e0171157. doi: 10.1371/journal.pone.0171157.", "ArticleIdList": ["10.1371/journal.pone.0171157", "PMC5279772", "28135339"]}, {"Citation": "Hu H, Wang F, Wang M, Liu Y, Wu H, Chen X, et al. FAM83A is amplified and promotes tumorigenicity in non-small cell lung cancer via ERK and PI3K/Akt/mTOR pathways. Int J Med Sci. 2020;17(6):807\u201314. doi: 10.7150/ijms.33992.", "ArticleIdList": ["10.7150/ijms.33992", "PMC7085261", "32218702"]}, {"Citation": "Parameswaran N, Bartel CA, Hernandez-Sanchez W, Miskimen KL, Smigiel JM, Khalil AM, et al. A FAM83A positive feed-back loop drives survival and tumorigenicity of pancreatic ductal adenocarcinomas. Sci Rep. 2019;9(1):13396. doi: 10.1038/s41598-019-49475-5.", "ArticleIdList": ["10.1038/s41598-019-49475-5", "PMC6746704", "31527715"]}, {"Citation": "Zheng Y-W, Li Z-H, Lei L, Liu C-C, Wang Z, Fei L-R, et al. FAM83A promotes lung cancer progression by regulating the WNT and HIPPO signaling pathways and indicates poor prognosis. Front Oncol. 2020;10:180. doi: 10.3389/fonc.2020.00180.", "ArticleIdList": ["10.3389/fonc.2020.00180", "PMC7066079", "32195172"]}, {"Citation": "Lan C, Liu C-C, Nie X-C, Lei L, Xiao Z-X, Li M-X, et al. FAM83A promotes the proliferative and invasive abilities of cervical cancer cells via epithelial-mesenchymal transition and the WNT signaling pathway. J Cancer. 2021;12(21):6320\u20139. doi: 10.7150/jca.62563.", "ArticleIdList": ["10.7150/jca.62563", "PMC8489145", "34659522"]}, {"Citation": "Liu C, Jiang Y, Han B. miR-613 suppresses chemoresistance and stemness in Triple-Negative breast cancer by targeting FAM83A. Cancer Manag Res. 2020;12:12623\u201333. doi: 10.2147/CMAR.S276316.", "ArticleIdList": ["10.2147/CMAR.S276316", "PMC7733386", "33324107"]}, {"Citation": "Zhou C, Liang Y, Zhou L, Yan Y, Liu N, Zhang R, et al. TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signaling and autophagy via the MIR454-FAM83A-TSPAN1 axis in pancreatic cancer. Autophagy. 2021;17(10):3175\u201395. doi: 10.1080/15548627.2020.1826689.", "ArticleIdList": ["10.1080/15548627.2020.1826689", "PMC8525961", "32972302"]}, {"Citation": "Tirado-Hurtado I, Fajardo W, Pinto JA. DNA damage inducible transcript 4 gene: the switch of the metabolism as potential target in Cancer. Front Oncol. 2018;8:106. doi: 10.3389/fonc.2018.00106.", "ArticleIdList": ["10.3389/fonc.2018.00106", "PMC5906527", "29707520"]}, {"Citation": "Du F, Sun L, Chu Y, Li T, Lei C, Wang X, et al. DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways. Cancer Commun Lond Engl. 2018;38(1):45. doi: 10.1186/s40880-018-0315-y.", "ArticleIdList": ["10.1186/s40880-018-0315-y", "PMC6034313", "29976242"]}, {"Citation": "Yamada T, Park CS, Mamonkin M, Lacorazza HD. Transcription factor ELF4 controls the proliferation and homing of CD8 + T cells via the Kr\u00fcppel-like factors KLF4 and KLF2. Nat Immunol. 2009;10(6):618\u201326. doi: 10.1038/ni.1730.", "ArticleIdList": ["10.1038/ni.1730", "PMC2774797", "19412182"]}, {"Citation": "Liu T, Yao Y, Zhang G, Wang Y, Deng B, Song J, et al. A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis. Oncotarget. 2017;8(10):16728\u201343. doi: 10.18632/oncotarget.14377.", "ArticleIdList": ["10.18632/oncotarget.14377", "PMC5369997", "28052010"]}, {"Citation": "Howard JC, Yousefi S, Cheong G, Bernstein A, Ben-David Y. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV. Oncogene. 1993;8(10):2721\u20139.", "ArticleIdList": ["8378083"]}, {"Citation": "Wang C, Sample KM, Gajendran B, Kapranov P, Liu W, Hu A, et al. FLI1 induces megakaryopoiesis gene expression through WAS/WIP-dependent and independent mechanisms; implications for Wiskott-Aldrich Syndrome. Front Immunol. 2021;12:607836. doi: 10.3389/fimmu.2021.607836.", "ArticleIdList": ["10.3389/fimmu.2021.607836", "PMC7953068", "33717090"]}, {"Citation": "Di Bello E, Zwergel C, Mai A, Valente S. The innovative potential of Statins in cancer: new targets for New Therapies. Front Chem. 2020;8:516. doi: 10.3389/fchem.2020.00516.", "ArticleIdList": ["10.3389/fchem.2020.00516", "PMC7312214", "32626692"]}, {"Citation": "Ben-David Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 1991;5(6):908\u201318. doi: 10.1101/gad.5.6.908.", "ArticleIdList": ["10.1101/gad.5.6.908", "2044959"]}, {"Citation": "Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin invest. 2002;109(9):1125\u201331. doi: 10.1172/JCI0215593.", "ArticleIdList": ["10.1172/JCI0215593", "PMC150968", "11994399"]}, {"Citation": "Phillips MC. New insights into the determination of HDL structure by apolipoproteins: thematic review series: high density lipoprotein structure, function, and metabolism. J Lipid Res. 2013;54(8):2034\u201348. doi: 10.1194/jlr.R034025.", "ArticleIdList": ["10.1194/jlr.R034025", "PMC3708355", "23230082"]}, {"Citation": "Broitman SA. Dietary cholesterol, serum cholesterol, and colon cancer: a review. Adv Exp Med Biol. 1986;206:137\u201352.", "ArticleIdList": ["3296679"]}, {"Citation": "Van Wyhe RD, Rahal OM, Woodward WA. Effect of statins on breast cancer recurrence and mortality: a review. Breast Cancer Dove Med Press. 2017;9:559\u201365.", "ArticleIdList": ["PMC5716320", "29238220"]}, {"Citation": "Ness GC, Gertz KR. Increased sensitivity to dietary cholesterol in diabetic and hypothyroid rats associated with low levels of hepatic HMG-CoA reductase expression. Exp Biol Med Maywood NJ. 2004;229(5):407\u201311. doi: 10.1177/153537020422900508.", "ArticleIdList": ["10.1177/153537020422900508", "15096652"]}, {"Citation": "Cipriano R, Graham J, Miskimen KLS, Bryson BL, Bruntz RC, Scott SA, et al. FAM83B mediates EGFR- and RAS-driven oncogenic transformation. J Clin Invest. 2012;122(9):3197\u2013210. doi: 10.1172/JCI60517.", "ArticleIdList": ["10.1172/JCI60517", "PMC3428078", "22886302"]}, {"Citation": "Parmar KM, Nambudiri V, Dai G, Larman HB, Gimbrone MA, Garc\u00eda-Carde\u00f1a G. Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J Biol Chem. 2005;280(29):26714\u20139. doi: 10.1074/jbc.C500144200.", "ArticleIdList": ["10.1074/jbc.C500144200", "15878865"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "10", "Day": "4"}, {"Year": "2023", "Month": "3", "Day": "15"}, {"Year": "2023", "Month": "4", "Day": "6", "Hour": "10", "Minute": "16"}, {"Year": "2023", "Month": "4", "Day": "4", "Hour": "23", "Minute": "46"}, {"Year": "2023", "Month": "4", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "4", "Day": "4"}], "PublicationStatus": "epublish", "ArticleIdList": ["37016335", "PMC10071686", "10.1186/s12885-023-10742-4", "10.1186/s12885-023-10742-4"]}}], "PubmedBookArticle": []}